Follow up policy after treatment for Hodgkin's disease: Too many clinic visits and routine tests

Radford, J.A.; Eardley, A.
February 1997
BMJ: British Medical Journal (International Edition);2/1/97, Vol. 314 Issue 7077, p343
Academic Journal
Investigates the effectiveness of routine clinic review in detecting relapse following treatment for Hodgkin's disease. Methodology; Outpatient review and relapse; Risk of relapse; Cause of relapse; Functions of routine review after treatment for Hodgkin's disease; Recommendations.


Related Articles

  • G-CSF plus PBPCT offers cost-effective alternative to ABMT.  // Formulary;Nov95, Vol. 30 Issue 11, p652 

    Suggests that the combination of peripheral blood progenitor cell (PBPC) transplantation and colony-stimulating factor (G-CSF) is a cost effective treatment for Hodgin's disease or lymphoma. Comparison with autologous bone marrow transplantation costs; Comments of Thomas Smith of Virginia...

  • Non-hodgkin's lymphoma. Patlak, Margie // FDA Consumer;Dec96, Vol. 30 Issue 10, p20 

    Reports that the Non-Hodgkin's (NHL) lymphoma is now the sixth most common cancer in the United States. Symptoms of NHL; Treatments for NHL; How doctors determine the stage of the cancer according to the number and location of tumors; What procedure is used to determine the type of NHL cancer;...

  • Discussion about treatment of early-stage Hodgkin's lymphoma needed radiation oncologist. Prosnitz, Leonard R.; Kelsey, Christopher // Hem/Onc Today;4/10/2013, Vol. 14 Issue 7, p7 

    The article discusses the highlights of a roundtable discussion about the treatment of early-stage Hodgkin's lymphoma featured on the December 25, 2013 issue of "Hematology/Oncology Today."

  • Naturopathy Complements Chemo. Bennett, Peter // Alive: Canada's Natural Health & Wellness Magazine;Apr2002, Issue 234, p46 

    Focuses on the importance of naturopathy in reducing the side effects of conventional therapy in treating Hodgkin's lymphoma. Strategies for managing health challenges; Comprehensiveness of the natural program to fight cancer; Risk of chemotherapy treatment for cancer.

  • Doxorubicin liposomal.  // Reactions Weekly;2/4/2012, Issue 1387, p17 

    The article describes the case of a 37-year-old man developed palmoplantar erythrodysaesthesia (PPE) while receiving pegylated (PLD) and non-pegylated doxorubicin (NPLD) liposomal for Hodgkin's disease.

  • Osteosarcoma in an adolescent previously treated for Hodgkin's Disease. Kourti, M.; Sidi, V.; Papakonstantinou, E. // Hippokratia;2014, Vol. 18 Issue 1, p96 

    A letter to the editor is presented which reveals the development of a secondary tumor or osteosarcoma in an adolescent after treatment for Hodgkin's disease.

  • Non-Hodgkin's lymphoma trials in elderly look beyond CHOP. McNeil, Caroline; McNeil, C // JNCI: Journal of the National Cancer Institute;02/18/98, Vol. 90 Issue 4, p266 

    Presents information on researchers' launch of a randomized trial for elderly patients with intermediate-grade non-Hodgkin's lymphoma (NHL) in December, 1997. Why this trial was launched; Indepth look at the trial; Statistical information on the increase of NHL; Comments from Joseph M. Connors,...

  • Procarbazine. Spivack, Samuel D. // Annals of Internal Medicine;Dec74, Vol. 81 Issue 6, p795 

    Deals with the developments in the use of procarbazine since its approval in 1969 for the treatment of Hodgkin's disease. Mechanism of action of the drug; Other clinical uses of the agent; Other diseases in which procarbazine is useful; Potential toxicities of the drug.

  • Hodgkins disease. Ferme, C; Cosset, J M; Fervers, B; Sebban, C; Cutuli, B; Henry-Amar, M; Stines, J; Giammarile, F; Bey, P; Philip, T // British Journal of Cancer;5/2/2001 Supplement 2, Vol. 84, p55 

    Focuses on the treatment strategies of Hodgkin's disease (HD). Description of standards, options and recommendations for the management of HD in 2001; Use of surgery, radiotherapy and chemotherapy for the treatment of HD.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics